About Contact Us Careers

HLA Typing for Transplant Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2629
Published Date: Oct 15, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the HLA Typing for Transplant Landscape

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Immucor, Inc.
Illumina, Inc.
CareDx, Inc.
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
F. Hoffman-La Roche Ltd.
Biofortuna Limited
Takara Bio Inc.
Omixon Inc.

Browse Key Market Insights with Data Illustration:

HLA Typing for Transplant Market Size & Share, Growth Trends 2036

In the News

Author Credits: Radhika Pawar

Report ID: 2629
Published Date: Oct 15, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of HLA typing for transplant is estimated at USD 843.51 million.

HLA Typing for Transplant Market size was over USD 803.65 million in 2023 and is anticipated to cross USD 1.75 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals and technological advancements in the field of transplant diagnostics.

The major players in the market are Immucor, Inc., Illumina, Inc., CareDx, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Biofortuna Limited, Takara Bio Inc., Omixon Inc., and others.

Inquiry Before Buying Request Free Sample